DNASENSE ApS: Financial statements 2020
CVR: 36036869
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
DNASENSE ApS (CVR 36036869) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,445,856 and a net result of DKK -1,081,586 compared with DKK 678,650 the year before. That is a decrease of 57.2% compared with the year before. Equity in the 2020 report amounted to DKK -92,909. The company had 5 employees in the financial year.
- Gross Profit
- DKK 1,445,856
- Profit/Loss
- DKK -1,081,586
- Equity
- DKK -92,909
- Total Assets
- DKK 870,745
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.4 mio. | -1.1 mio. | -93 t. | 5 |
| 2019 | - | 3.4 mio. | 679 t. | 1.3 mio. | 4 |
| 2018 | - | 2.3 mio. | 524 t. | 910 t. | 2 |
| 2017 | - | 1.8 mio. | 673 t. | 886 t. | 1 |
| 2016 | - | 1.1 mio. | 359 t. | 513 t. | - |
Official annual report
How creditworthy is DNASENSE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of July 1, 2020, Mads Toft Søndergaard is registered as director of DNASENSE ApS.
As of July 1, 2020, Mads Albertsen has stepped down as director of DNASENSE ApS.
About DNASENSE ApS
DNASENSE ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Mads Toft Søndergaard. The board consists of Anders Christian Neto de Sousa Grøn (chair), Anders Mohr Christensen, Henrik Bjørn Nielsen and Manoj Nirmal Dadlani. The company is owned by Clinical-Microbiomics A/S. The company has 15 employees (2018). In 2025, the company reported a gross profit of DKK 7,915,337 and a net result of DKK 894,729. Equity in the 2025 report amounted to DKK 1,639,012.